Fehring Nicolas A. Form 3 Filed 2023-02-01

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	02/28/2011
Estimated average burden
hours per response		0.5

1. Name and Address of Reporting Person ^*

Fehring Nicolas A.

2. Date of Event Requiring Statement (Month/Day/Year)

01/30/2023

3. Issuer Name and Ticker or Trading Symbol

INTERNATIONAL BUSINESS MACHINES CORP [IBM]

(Last)

(First)

(Middle)

IBM CORPORATION, ONE NEW ORCHARD ROAD

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
VP, Controller

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

ARMONK, NY 10504

(City)

(State)

(Zip)

6. Individual or Joint/Group Filing

(Check applicable line)

__X__ Form Filed by One Reporting Person
_____ Form Filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,061.434	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Emp. Stock Option (right to buy)	02/21/2023⁽¹⁾	02/20/2032⁽¹⁾	Common Stock	7,359	$124.51	D
Rst. Stock Unit	⁽²⁾	⁽²⁾	Common Stock	2,848	$ 0	D
Rst. Stock Unit	⁽³⁾	⁽³⁾	Common Stock	386	$ 0	D
Rst. Stock Unit	⁽⁴⁾	⁽⁴⁾	Common Stock	1,051	$ 0	D
Rst. Stock Unit	⁽⁵⁾	⁽⁵⁾	Common Stock	1,545	$ 0	D
Rst. Stock Unit	⁽⁶⁾	⁽⁶⁾	Common Stock	5,484	$ 0	D
Rst. Stock Unit	⁽⁷⁾	⁽⁷⁾	Common Stock	1,578	$ 0	D

Explanation of Responses:

1.	These derivative securities vest in four equal annual installments, the first vesting being on the date exercisable shown. All expire on the expiration date shown above.
2.	Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 2,848 of these units on June 3, 2023.
3.	Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 386 of these units on June 7, 2023.
4.	Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 524 of these units on June 8, 2023 and for 527 of these units on June 8, 2024.
5.	Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 514 of these units on June 8, 2023, for 514 of these units on June 8, 2024, and for 517 of these units on June 8, 2025.
6.	Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 2,742 of these units on September 1, 2024, and for 2,742 of these units on September 1, 2025.
7.	Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 394 of these units on February 21, 2023, for 394 of these units on February 21, 2024, for 394 of these units on February 21, 2025, and for 396 of these units on February 21, 2026.

	Signatures
	D. Glowienka on behalf of N. A. Fehring	02/01/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

International Business Machines
New Orchard Road
Armonk, NY 10504

January 30, 2023


Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549

I hereby authorize each of the following individuals,
whose signatures appear below, as well as each of the
International Business Machines Corporation (IBM) employees
holding the titles of Secretary; Assistant Secretary;
Vice President, Compensation and Benefits; Vice
President, Executive Compensation; and Manager, Executive
Compensation Operations and Officer Services; and any
employee of IBM designated in writing by the Secretary of
IBM, to sign and file on my behalf as an Executive Officer
of IBM any Securities and Exchange Commission forms or
documentsin connection with any transactions by me in IBM
securities,including without limitation Form 3, Form 4,
and Form 5 under the Securities Exchange Act of 1934 and
Form 144 under the Securities Act of 1933. The specimen
signatures provided below may be signed on separate
documents, and such documents taken together shall
constitute a single document.


J. Daly		_____/s/ J. Daly_____________________
P. E. Dunkle, Jr.	______/s/ P. E. Dunkle, Jr.__________
D. Glowienka	______/s/ D. Glowienka________________
R. Hayes	___________/s/ R. Hayes_____________________
L. Mallardi	____________/s/ L. Mallardi_________________
J. Mancillas	______/s/ J. Mancillas________________
J. Pomazal	____________/s/ J. Pomazal___________________
F. Sedlarcik	______/s/ F. Sedlarcik_________________
L. Sousa	____________/s/ L. Sousa____________________


This authorization shall remain in effect for as long as
I remain an executive officer of IBM.


              			Very truly yours,

              			/s/ Nicolas Fehring
				Nicolas Fehring